Hims & Hers Health (HIMS)
(Delayed Data from NYSE)
$12.50 USD
+0.23 (1.87%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $12.52 +0.02 (0.16%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth C Momentum A VGM
Balance Sheet
Fiscal Year End for Hims & Hers Health, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 221 | 180 | 247 | 1 | 2 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 22 | 22 | 14 | 0 | 0 |
Other Current Assets | 22 | 15 | 9 | 0 | 0 |
Total Current Assets | 265 | 217 | 270 | 1 | 2 |
Net Property & Equipment | 36 | 0 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 205 | 203 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 129 | 133 | 137 | 0 | 0 |
Deposits & Other Assets | 1 | 12 | 9 | 0 | 0 |
Total Assets | 441 | 366 | 421 | 206 | 205 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 43 | 32 | 20 | 0 | 0 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 29 | 12 | 12 | 4 | 1 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 15 | 1 | 46 | 1 | 0 |
Total Current Liabilities | 88 | 48 | 79 | 5 | 1 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 3 | 3 | 196 | 199 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 97 | 55 | 86 | 201 | 200 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 712 | 657 | 614 | 7 | 4 |
Retained Earnings | -368 | -345 | -279 | -2 | 1 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 344 | 312 | 335 | 5 | 5 |
Total Liabilities & Shareholder's Equity | 441 | 366 | 421 | 206 | 205 |
Total Common Equity | 344 | 312 | 335 | 5 | 5 |
Shares Outstanding | 213.40 | 208.40 | 204.70 | 6.30 | 25.10 |
Book Value Per Share | 1.61 | 1.50 | 1.63 | 0.79 | 0.20 |
Fiscal Year End for Hims & Hers Health, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 221 | 213 | 193 | 184 |
Receivables | NA | 0 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 22 | 22 | 21 | 21 |
Other Current Assets | NA | 22 | 16 | 20 | 20 |
Total Current Assets | NA | 265 | 250 | 235 | 226 |
Net Property & Equipment | NA | 36 | 28 | 0 | 0 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 129 | 130 | 131 | 132 |
Deposits & Other Assets | NA | 1 | 1 | 20 | 14 |
Total Assets | NA | 441 | 414 | 390 | 376 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 43 | 42 | 38 | 38 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 29 | 27 | 20 | 14 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 15 | 11 | 7 | 3 |
Total Current Liabilities | NA | 88 | 83 | 67 | 56 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 4 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 97 | 85 | 70 | 64 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 712 | 698 | 682 | 668 |
Retained Earnings | NA | -368 | -369 | -362 | -355 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 344 | 329 | 320 | 313 |
Total Liabilities & Shareholder's Equity | NA | 441 | 414 | 390 | 376 |
Total Common Equity | 0 | 344 | 329 | 320 | 313 |
Shares Outstanding | 214.20 | 213.40 | 211.90 | 210.80 | 209.30 |
Book Value Per Share | 0.00 | 1.61 | 1.55 | 1.52 | 1.49 |